Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
溴结构域抑制剂 OTX015/MK-8628 对 ALK 阳性间变性大细胞淋巴瘤的治疗效果:克服耐药表型的替代方法
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.12876
Michela Boi, Maria Todaro, Valentina Vurchio, Shao Ning Yang, John Moon, Ivo Kwee, Andrea Rinaldi, Heng Pan, Ramona Crescenzo, Mangeng Cheng, Leandro Cerchietti, Olivier Elemento, Maria E Riveiro, Esteban Cvitkovic, Francesco Bertoni, Giorgio Inghirami; AIRC 5xMille Consortium ‘Genetics-Driven Targe